scholarly journals Metabolism and toxicity of hydrochlorofluorocarbons: current knowledge and needs for the future.

1991 ◽  
Vol 96 ◽  
pp. 185-191 ◽  
Author(s):  
M W Anders
Keyword(s):  
2021 ◽  
Vol 22 (14) ◽  
pp. 7463
Author(s):  
Ismat Majeed ◽  
Komal Rizwan ◽  
Ambreen Ashar ◽  
Tahir Rasheed ◽  
Ryszard Amarowicz ◽  
...  

The Mimosa genus belongs to the Fabaceae family of legumes and consists of about 400 species distributed all over the world. The growth forms of plants belonging to the Mimosa genus range from herbs to trees. Several species of this genus play important roles in folk medicine. In this review, we aimed to present the current knowledge of the ethnogeographical distribution, ethnotraditional uses, nutritional values, pharmaceutical potential, and toxicity of the genus Mimosa to facilitate the exploitation of its therapeutic potential for the treatment of human ailments. The present paper consists of a systematic overview of the scientific literature relating to the genus Mimosa published between 1931 and 2020, which was achieved by consulting various databases (Science Direct, Francis and Taylor, Scopus, Google Scholar, PubMed, SciELO, Web of Science, SciFinder, Wiley, Springer, Google, The Plant Database). More than 160 research articles were included in this review regarding the Mimosa genus. Mimosa species are nutritionally very important and several species are used as feed for different varieties of chickens. Studies regarding their biological potential have shown that species of the Mimosa genus have promising pharmacological properties, including antimicrobial, antioxidant, anticancer, antidiabetic, wound-healing, hypolipidemic, anti-inflammatory, hepatoprotective, antinociceptive, antiepileptic, neuropharmacological, toxicological, antiallergic, antihyperurisemic, larvicidal, antiparasitic, molluscicidal, antimutagenic, genotoxic, teratogenic, antispasmolytic, antiviral, and antivenom activities. The findings regarding the genus Mimosa suggest that this genus could be the future of the medicinal industry for the treatment of various diseases, although in the future more research should be carried out to explore its ethnopharmacological, toxicological, and nutritional attributes.


2021 ◽  
pp. 103673
Author(s):  
Zhao-Liang Li ◽  
Pei Leng ◽  
Cheng-Hu Zhou ◽  
Kun-Shan Chen ◽  
Fang-Cheng Zhou ◽  
...  

Author(s):  
Alyssa M. Lombardo ◽  
Ciro Andolfi ◽  
Abhishek P. Deshpande ◽  
Joshua M. Aizen ◽  
Pankaj P. Dangle ◽  
...  

Dermatology ◽  
2020 ◽  
Vol 236 (6) ◽  
pp. 571-592 ◽  
Author(s):  
Christina Bergqvist ◽  
Khaled Ezzedine

Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of the population worldwide. The disease is characterized by the selective loss of melanocytes which results in typical nonscaly, chalky-white macules. In recent years, considerable progress has been made in our understanding of the pathogenesis of vitiligo which is now clearly classified as an autoimmune disease. Vitiligo is often dismissed as a cosmetic problem, although its effects can be psychologically devastating, often with a considerable burden on daily life. In 2011, an international consensus classified segmental vitiligo separately from all other forms of vitiligo, and the term vitiligo was defined to designate all forms of nonsegmental vitiligo. This review summarizes the current knowledge on vitiligo and attempts to give an overview of the future in vitiligo treatment.


Cells ◽  
2020 ◽  
Vol 9 (1) ◽  
pp. 114
Author(s):  
Lisa Linck-Paulus ◽  
Claus Hellerbrand ◽  
Anja K. Bosserhoff ◽  
Peter Dietrich

In this review, we summarize the current knowledge on miRNAs as therapeutic targets in two cancer types that were frequently described to be driven by miRNAs—melanoma and hepatocellular carcinoma (HCC). By focusing on common microRNAs and associated pathways in these—at first sight—dissimilar cancer types, we aim at revealing similar molecular mechanisms that are evolved in microRNA-biology to drive cancer progression. Thereby, we also want to outlay potential novel therapeutic strategies. After providing a brief introduction to general miRNA biology and basic information about HCC and melanoma, this review depicts prominent examples of potent oncomiRs and tumor-suppressor miRNAs, which have been proven to drive diverse cancer types including melanoma and HCC. To develop and apply miRNA-based therapeutics for cancer treatment in the future, it is essential to understand how miRNA dysregulation evolves during malignant transformation. Therefore, we highlight important aspects such as genetic alterations, miRNA editing and transcriptional regulation based on concrete examples. Furthermore, we expand our illustration by focusing on miRNA-associated proteins as well as other regulators of miRNAs which could also provide therapeutic targets. Finally, design and delivery strategies of miRNA-associated therapeutic agents as well as potential drawbacks are discussed to address the question of how miRNAs might contribute to cancer therapy in the future.


2001 ◽  
Vol 23 (2) ◽  
pp. 192-197 ◽  
Author(s):  
Dick Mårtenson
Keyword(s):  

2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Patricia J. Folgarait

This review updates and summarizes the current knowledge about the interaction of leaf-cutter ants and their parasitoids by providing comparable data forAcromyrmexandAttaants. First, an overview of the relevant aspects of the biology and taxonomy of leaf cutters and of their parasitoids is provided. Second, I show the peculiarities of the parasitoids attacking behaviors towards their host as well as the responses or ant defenses against the phorids exhibited by their hosts. Third, I discuss relevant aspects of the interactions between hosts and parasitoids. Finally, the review ends demonstrating why these phorids could be promising biological control agents of leaf-cutter pests and suggests priority lines of research for the future.


1995 ◽  
Vol 112 (5) ◽  
pp. P172-P172 ◽  
Author(s):  
David B. Hom ◽  
Edward Szachowicz

Educational objectives: To better understand the current knowledge of polypeptide growth factors and to gain insight in the future therapeutic potential of growth factors.


Sign in / Sign up

Export Citation Format

Share Document